z-logo
open-access-imgOpen Access
Primary solitary fibrous tumor of the thyroid gland: A review starting from a case report
Author(s) -
Ion Negură,
AUTHOR_ID,
Victor Ianole,
Radu Dănilă,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2021
Publication title -
archive of clinical cases
Language(s) - English
Resource type - Journals
ISSN - 2360-6975
DOI - 10.22551/2021.33.0804.10193
Subject(s) - thyroid , solitary fibrous tumor , medicine , pathology , soft tissue , differential diagnosis , peritoneum , cd34 , pathological , thyroid neoplasm , neoplasm , thyroid cancer , biology , stem cell , genetics
Primary solitary fibrous tumor (SFT) of the thyroid gland is a rare mesenchymal tumor with fibroblastic differentiation, ramified, thin-walled, enlarged (staghorn) vessels and specific NAB2-STAT6 gene fusion, which is more commonly found in pleura and peritoneum. This neoplasm can be located in a variety of anatomical sites outside pleura and peritoneum including bone, visceral organs and soft tissues, head and neck examples representing only 10-15% of the extra-pleural and extra-peritoneal tumors. Diagnosing this entity can be difficult, especially in thyroid gland, mainly because of the rarity of this neoplasm, but presence of characteristic microscopic features together with positivity for STAT6 and CD34 can confirm the diagnosis and exclude other differential diagnosis. Information about the diagnosis and treatment options of thyroid SFTs is limited but almost all primary thyroid SFTs have a good prognosis and indolent clinical course. Clinical surveillance is still necessary because some SFTs can be aggressive. Raising awareness regarding extra-pleural and extra-peritoneal location of this tumor in endocrine organs can help to better manage these patients. We report the case of a 34-year-old female with primary SFT of the thyroid gland. Additionally, we review the literature for the main clinical, paraclinical and pathological features of this neoplasm.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here